After just a few years on the market, a new wave of GLP-1 drugs approved for weight loss have upended what we know about obesity. By now, these are household names: Mounjaro. Wegovy. Zepbound ...

Share on Pinterest Women with diabetes may get the strongest cardiovascular protection from GLP-1 agonists. Image credit: Kathryn Gamble for The Washington Post via Getty Images. Diabetes ...

A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...

What would you say if an Edmonton business started up with a $25,000 investment in 1971, then grew in value to Cdn$3.53 billion today? What would you say if that same business had successfully ...

In this article, we are going to take a look at where Global Partners LP (NYSE:GLP) stands against other oil & gas stocks that are skyrocketing so far in 2025. The oil & gas sector has ...

Today will start dry with some bright spells. By noon, cloud will build in from the east, leaving cloudy skies for the rest of the day along with a few patches of light rain. Tonight Tonight will ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

Earlier this month, the FDA put out a statement saying that it, too, was concerned about patients and healthcare professionals turning to unapproved versions of GLP-1 drugs as an option for weight ...

After hours: February 7 at 4:09:01 PM EST Loading Chart for GLP ...

Coffee’s recent dizzying rally has been fueled by a lack of insight on future supply and short-term speculation, resulting in pricier brews for consumers, according to Andrea Illy, chairman of ...